About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Scn5atm2.1Care
targeted mutation 2.1, Carol Ann Remme
MGI:5705587
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Scn5atm2.1Care/Scn5atm2.1Care B6J.129P2(Cg)-Scn5atm2.1Care MGI:5751745


Genotype
MGI:5751745
hm1
Allelic
Composition
Scn5atm2.1Care/Scn5atm2.1Care
Genetic
Background
B6J.129P2(Cg)-Scn5atm2.1Care
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Scn5atm2.1Care mutation (1 available); any Scn5a mutation (105 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• unexpectedly, homozygotes are born at normal Mendelian ratios and are viable throughout adulthood in the absence of apparent illesses or increased mortality

cardiovascular system
N
• at 3-5 months of age, homozygotes have normal heart weight:body weight ratios and show no signs of cardiac fibrosis, inflammatory infiltrates, or cardiomyocyte hypertrophy
• heart rate and QTc interval are not significantly altered
• optical mapping in isolated Langendorff-perfused hearts showed significantly increased total left ventricular activation times and significantly decreased longitudinal and transversal conduction velocities in mutant ventricles relative to wild-type ventricles
• ventricular conduction velocity is preferentially reduced in the transversal direction to myocardial fiber orientation, leading to increased anisotropy of ventricular conduction (increased longitudinal/transversal conduction velocity ratio)
• atrial and atrioventricular and, most notably, His-ventricular conduction are significantly slower in mutant hearts relative to wild-type hearts
• significant prolongation of the PR interval
• increase in the flecainide-induced prolongation of the PR interval compared to wild-type controls
• significant prolongation of the P wave
• increase in the flecainide-induced prolongation of the P wave compared to wild-type controls
• significant prolongation of the QRS duration
• increase in the flecainide-induced prolongation of the QRS duration compared to wild-type controls
• isolated ventricular cardiomyocytes show a ~36% reduction in peak sodium current (INa) density but no changes in voltage dependence of INa activation and inactivation
• surprisingly, peak INa density is drastically reduced by ~62% at the cardiomyocyte lateral membrane but remains normal at the intercalated disk region
• maximum action potential (AP) upstroke velocity (dV/dtmax) is reduced by ~35% but resting membrane potential is not significantly altered
• a small but significant decrease is seen in the AP amplitude but AP durations at 30, 50, and 90% repolarization are not significantly altered
• no differences in Ba2+-sensitive inward rectifier potassium currents or in calcium channels are observed





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory